Cancer Biopsy Market : Technology Advancements, Industry Insights, Trends And Forecast 2033

The cancer biopsy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Cancer Biopsy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The cancer biopsy market size has grown rapidly in recent years. It will grow from $22.12 billion in 2023 to $25.08 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increasing awareness of breast cancer liquid biopsy procedures, rising awareness of inherited oncology disorders and genetic testing, increasing adoption of liquid biopsies, increasing demand of for minimally invasive biopsy treatments, increasing demand for tissue biopsies.
The cancer biopsy market size is expected to see rapid growth in the next few years. It will grow to $41.65 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to an increase in the number of patients, the growing elderly population, the growing number of patients suspected of having breast cancer, the rise in cancer cases, an increase in the diagnosis and biopsies testing, increase in the number of patients. Major trends in the forecast period include technological advancements, artificial intelligence and machine learning, integration of multi-omics, product innovations, and point-of-care biopsy devices.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cancer-biopsy-global-market-report

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers –
The increasing prevalence of cancer is expected to propel the growth of the cancer biopsy market going forward. Cancer is a complex group of diseases characterized by the abnormal growth and spread of cells. The increasing prevalence of cancer is due to several factors, such as lifestyle changes and urbanization, environmental pollution, tobacco and alcohol consumption, healthcare access, and awareness. A cancer biopsy is used to diagnose and assess cancer type, stage, and spread by extracting and analyzing tissue or cells from a suspicious area. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, in the United States there were 1,958,310 new cancer cases and 609,820 cancer deaths. Furthermore, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a large number of deaths. Therefore, the increasing prevalence of cancer drives the cancer biopsy market.

Market Trends –
Major companies operating in the cancer biopsy market are developing liquid biopsy techniques to enable non-invasive, early detection and monitoring of cancer, improve patient outcomes, and allow for more personalized treatment approaches. Liquid biopsy is an advanced, non-invasive diagnostic technique that detects and analyzes genetic material from a blood sample, such as circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. For instance, in May 2023, Labcorp, a US-based company specializing in the manufacturing of cancer biopsies, launched Labcorp Plasma Focus, a plasma-focused liquid biopsy to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) released from tumor cells into the bloodstream and can construct a genomic profile of the patient’s tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

The cancer biopsy market covered in this report is segmented –

1) By Type: Tissue Biopsies, Liquid Biopsies, Other Types
2) By Application: Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Other Applications
3) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Get an inside scoop of the cancer biopsy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19355&type=smp

Regional Insights –
North America was the largest region in the cancer biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

Table of Contents
1. Executive Summary
2. Cancer Biopsy Market Report Structure
3. Cancer Biopsy Market Trends And Strategies
4. Cancer Biopsy Market – Macro Economic Scenario
5. Cancer Biopsy Market Size And Growth
…..
27. Cancer Biopsy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model